• Explore /
  • Poster
  • / Real-world outcomes and safety in patients with VHL associated tumors receiving belzutifan.

Real-world outcomes and safety in patients with VHL associated tumors receiving belzutifan.

Abstract Poster

Authors

null

Anusha Chidharla

University of Kansas Cancer Center, Kansas City, KS

Anusha Chidharla , Ryan Fleer , Madison Murphy , Kelly Brunk , Jeffrey Holzbeierlein , Anup Kasi , Rahul Atul Parikh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Prevention, Risk Reduction, and Hereditary Cancer

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Hereditary Cancer Syndromes

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 10515)

DOI

10.1200/JCO.2023.41.16_suppl.10515

Abstract #

10515

Poster Bd #

148

Abstract Disclosures

Similar Posters

First Author: Othon Iliopoulos

First Author: Lin Wang

First Author: Othon Iliopoulos

First Author: David F. McDermott